Search Results
Results found for "Heptares Therapeutics"
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
Leverage this model to stay ahead of therapeutic complexity.
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
puzzles and underscores the importance of understanding cellular processes at the molecular level for therapeutic
- The development of modulators for lysophosphatidic acid receptors: A comprehensive review
the current status of ligand development targeting LPA receptors to modulate LPA signaling and their therapeutic
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
20th World Congress of Basic and Clinical Pharmacology GPCR Jobs Scientist I Cell Biology - Tectonic Therapeutic
- GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026
Endocrine Metabolic GPCRs 2026 and Biophysical Society Meeting previews; positive ACCESS data for Structure Therapeutics
- Your GPCR Program Decisions Depend on Good Data Interpretation
drug discovery; new strategies for inflammatory disease treatment; growth strategies from Tectonic Therapeutics
- Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic ...
indicated by the fact that about 40% of all drugs currently used in clinical practice mediate their therapeutic
- Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors
advancing the understanding of the effects of genetic mutations on GPCR function and provide a proof of therapeutic
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
Antibodies, Bias, and the Expanding Modality Landscape Antibody therapeutics are now entering spaces
- Recurrent high-impact mutations at cognate structural positions in class A G protein-coupled ...
cognate positions across GPCR paralogs opens a window into cancer mechanisms and potential approaches to therapeutics
- Understanding Enzyme Inhibition In GPCR Discovery Programs
When âinhibitionâ becomes activationâand how that insight fuels next-gen therapeutic design.
- đ° GPCR Weekly News, May 15 to 21, 2023
Hopkins, Exscientiaâs founder and CEO was elected a Fellow of the Academy of Medical Sciences Structure Therapeutics
- Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
implications for drug development, as targeting these non-cognate interactions could lead to novel therapeutic
- đ° GPCR Weekly News - January 2 to 8, 2023
Enter into Multitarget Antibody Discovery Research Collaboration Neurocrine Biosciences and Voyager Therapeutics
- GPCR Collaboration: From Models to Medicine
They offer extraordinary therapeutic promise âbut their complexity makes them one of the hardest targets
- Drug Discovery Pharmacology Principles That Turn Assays Into Real Medicines
Kenakin highlights that therapeutic efficacy depends on the period during which a drug is actively engaged
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
When a drug outlives its exposure , toxic interactions can be just as persistent as therapeutic ones.
- The Hidden Cost of Ambition in Biotech Leadership
A strong preclinical signal opens adjacent therapeutic areas.
- Interacting binding insights and conformational consequences of the differential activity of...
way for understanding the CBD pharmacology at a molecular level and aid in harnessing its potential therapeutic
- Dr. GPCR University registration is now open! Secure your spot now!
the atomic-level quaternary structure of short-lived GPCR oligomers in live cells Industry News Confo Therapeutics
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! â Dec 2 - 8, 2024
Pharmacology GPCR Jobs GPCR Molecular Pharmacologist Scientist - Biology Scientist I Cell Biology - Tectonic Therapeutic
- Exploring the Breakthroughs in GPCR Research
GPCRs remain one of the most prolific and fertile therapeutic drug targets.
- Advantages of Fluorescent Probes in GPCR Assays
GPCRs pose a critical challenge in drug discovery: a vast therapeutic potential with many targets yet
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
competitive edge: Â Learn to leverage restricted diffusion and rebinding to create drugs with longer therapeutic
- FDA Approval Is a Strategy Obstacle, Not a Paperwork Problem
4ď¸âŁ Comparative value: Have you positioned your therapeutic against the right standard or competitor,
- Artificial intelligence â faster, smarter, cheaper GPCR drug discovery
revolution of biased signalling of GPCRs comes the possibility of designing drugs that selectively activate therapeutically analyzing drug-target interactions and disease pathways, AI can identify potential candidates that may have therapeutic
- TM5-TM6: structural switches that modulate the coupling of serotonin receptors to Gs or Gi
understanding how serotonin receptors, one of the largest subfamilies of class A GPCRs and potential therapeutic
- đ° GPCR Weekly News - January 9 to 15, 2023
Foundation is awarding DKK 174 million in grants to seven âmind-bendingâ research collaborations GPCR Therapeutics
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
accurately reflect native biological processes and preclinical research can more reliably translate into therapeutic Trends in clinical success rates and therapeutic focus. Endosomal signaling of delta opioid receptors is an endogenous mechanism and therapeutic target for relief
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
Essential Frameworks for Precision Drug Discovery: An Insight into Advanced Strategies for Targeted Therapeutics



















